E-Mail from ASFX IR:
Hi there
Amazon is going great. They order about every day - it's the way they
operate. No big inventories, but we have it like clockwork now. The
ranking we have is amazing after just one week. Very pleased over
here.
NDD: We are transitioning out of the old model to the new one that has
arrived. Need new photos/artwork to go up. Packaging is new.
Uplisting and PRs: We are in the process of uplisting and have filed
with the SEC to become a fully reporting company; the first step in
the 2 step process.
We are not permitted to give "estimates" or dates as to the completion
of the process. It's an SEC matter and as such there are very strict
rules governing the whole process. However, we are told by our
attorneys that we are in the final stages in their opinion. They have
done many of these over the years and have a very good relationship
with the SEC.
The process generally is that from the first round of comments each
subsequent round gets halved. So if we started with 100 comments, next
round 50, next round 25, next round 10 or so. After that all the
remaining little items are dealt with over a couple of conference
calls with the final amendment going in for the record just ahead of
effectiveness. We are at the phone calls stage. The drastic reduction
in the amount of shares included on the statement was a great move and
has helped the process considerably.
After the statement is declared effective we then immediately apply to
FINRA to begin trading on the OTCBB.
The latest amendment to the S1 is at the auditors for sign off. Each
amendment that is to be filed has to go through the Independent
Auditors before filing. Should go in today.
As part of the process we are advised to keep any public announcements
to a minimum. Again, sorry we can't give specific dates - the SEC
does not in turn give us specific dates. However we believe we are in
the final stages which means weeks not months.
PLEASE NOTE: Thank you for contacting American Scientific Investor
Relations. If you have provided your return email, full name and your
location, please see the reply above or you will receive a reply
shortly. If however this information has not been included please
resubmit your request including the required information. If you
prefer to call the dedicated IR line at 561-948-4863, you will also be
required to supply the same information. No replies can be given
unless such information is provided. Thank you for your understanding.
Visit www.americansci.com and sign up for our email news and
announcements or you may submit a question or enquiry via the Investor
Relations section of the site or call +1-561-948-4863
AI
